Pathological findings with vacuoles in anti-mitochondrial antibody-positive inflammatory myopathy

Yuanchong Chen1,2, Wei Zhang1, He Lv1

  • 1Department of Neurology, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.

PubMed
Abstract

Insights

Anti-mitochondrial antibody (AMA)-positive inflammatory myopathy presents with systemic involvement and characteristic muscle vacuoles. This study details the clinical and pathological findings in three such cases.

Area of Science:

  • Rheumatology
  • Neurology
  • Immunology

Background:

  • Inflammatory myopathy can present with anti-mitochondrial antibody (AMA) positivity in a subset of patients.
  • This study focuses on three cases of AMA-positive inflammatory myopathy.

Purpose of the Study:

  • To report the clinical and pathological findings in patients with inflammatory myopathy and anti-mitochondrial antibody (AMA) positivity.
  • To investigate the presence of vacuoles in muscle biopsies of these patients.

Main Methods:

  • Retrospective review of clinical records from three AMA-positive myositis patients.
  • Analysis of muscle biopsy findings, including histopathology and immunohistochemistry.

Main Results:

  • Three middle-aged patients exhibited chronic proximal limb weakness, elevated creatine kinase, and AMA positivity.
  • Two patients met criteria for primary biliary cholangitis; all had cardiac involvement and proteinuria.
  • Muscle pathology revealed fiber degeneration, MHC-I positivity, complement deposition, and unique vacuoles.

Conclusions:

  • AMA-positive inflammatory myopathy is a multisystem disease.
  • Muscle biopsy findings in these patients can include vacuoles, in addition to inflammatory changes.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
819
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.5K